Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Systematic preclinical evaluation of CD33-directed chimeric antigen receptor T cell immunotherapy for acute myeloid leukemia defines optimized construct design
Haiying Qin, Lila Yang, John Chukinas, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 9, pp. e003149-e003149
Open Access | Times Cited: 56

Showing 1-25 of 56 citing articles:

Patient-derived xenograft models in cancer therapy: technologies and applications
Yihan Liu, Wantao Wu, Changjing Cai, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 181
Current advances and challenges in CAR T-Cell therapy for solid tumors: tumor-associated antigens and the tumor microenvironment
Ting Yan, Zhu Lingfeng, Jin Chen
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 108
The significant role of amino acid metabolic reprogramming in cancer
Xiaohong Liu, Bo Ren, Jie Ren, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 19
Primary CD33-targeting CAR-NK cells for the treatment of acute myeloid leukemia
Nawid Albinger, Rita Pfeifer, Marcus Nitsche, et al.
Blood Cancer Journal (2022) Vol. 12, Iss. 4
Open Access | Times Cited: 68
CD38 as a pan-hematologic target for chimeric antigen receptor T cells
Tina Glisovic‐Aplenc, Caroline Diorio, John Chukinas, et al.
Blood Advances (2023) Vol. 7, Iss. 16, pp. 4418-4430
Open Access | Times Cited: 35
New insights into immune cells in cancer immunotherapy: from epigenetic modification, metabolic modulation to cell communication
Sha Qin, Bin Xie, Qingyi Wang, et al.
MedComm (2024) Vol. 5, Iss. 6
Open Access | Times Cited: 12
Engineering Novel DNA Nanoarchitectures for Targeted Drug Delivery and Aptamer Mediated Apoptosis in Cancer Therapeutics
Abhisek Dwivedy, Dhyanesh Baskaran, Gaurav Sharma, et al.
Advanced Functional Materials (2025)
Open Access | Times Cited: 1
Restoration of LAT activity improves CAR T cell sensitivity and persistence in response to antigen-low acute lymphoblastic leukemia
Catherine Pham‐Danis, A. Novak, Etienne Danis, et al.
Cancer Cell (2025) Vol. 43, Iss. 3, pp. 482-502.e9
Open Access | Times Cited: 1
CAR-T cell therapy for hematological malignancies: Limitations and optimization strategies
Jiawen Huang, Xiaobing Huang, Juan Huang
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 33
Potent preclinical activity of FLT3-directed chimeric antigen receptor T-cell immunotherapy against <i>FLT3</i>- mutant acute myeloid leukemia and <i>KMT2A</i>-rearranged acute lymphoblastic leukemia
Lisa M Niswander, Zachary Graff, Christopher D. Chien, et al.
Haematologica (2022) Vol. 108, Iss. 2, pp. 457-471
Open Access | Times Cited: 32
Relapsed pediatric acute myeloid leukaemia: state-of-the-art in 2023
Grace Egan, Sarah K. Tasian
Haematologica (2023)
Open Access | Times Cited: 18
C-JUN overexpressing CAR-T cells in acute myeloid leukemia: preclinical characterization and phase I trial
Shiyu Zuo, Chuo Li, Xiaolei Sun, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Adoptive cell therapy for solid tumors beyond CAR-T: Current challenges and emerging therapeutic advances
Tingrui Zhang, Zongguang Tai, Fengze Miao, et al.
Journal of Controlled Release (2024) Vol. 368, pp. 372-396
Closed Access | Times Cited: 7
The Potential of Siglecs and Sialic Acids as Biomarkers and Therapeutic Targets in Tumor Immunotherapy
Haokang Feng, Jiale Feng, Xu Han, et al.
Cancers (2024) Vol. 16, Iss. 2, pp. 289-289
Open Access | Times Cited: 6
Paediatric Strategy Forum for medicinal product development of chimeric antigen receptor T-cells in children and adolescents with cancer
Andrew D.J. Pearson, Claudia Rössig, Crystal L. Mackall, et al.
European Journal of Cancer (2021) Vol. 160, pp. 112-133
Open Access | Times Cited: 33
Development of CAR T Cell Therapy in Children—A Comprehensive Overview
Michael Boettcher, Alexander Joechner, Ziduo Li, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 8, pp. 2158-2158
Open Access | Times Cited: 25
A perspective of immunotherapy for acute myeloid leukemia: Current advances and challenges
Ying Chen, Jishi Wang, Fengqi Zhang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 14
Universal CAR 2.0 to overcome current limitations in CAR therapy
Lara Sophie Schlegel, Coralie Werbrouck, Michael Boettcher, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Advances in Drug Delivery Systems for the Treatment of Acute Myeloid Leukemia
Xia Wu, Fangfang Wang, Xijing Yang, et al.
Small (2024) Vol. 20, Iss. 42
Closed Access | Times Cited: 5
Chimeric antigen receptor T-cell therapy for T-ALL and AML
Wenwen Wei, Dong Yang, Xi Chen, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 22
FGFR4-Targeted Chimeric Antigen Receptors Combined with Anti-Myeloid Polypharmacy Effectively Treat Orthotopic Rhabdomyosarcoma
Peter M. Sullivan, Rajesh Kumar, Wei Li, et al.
Molecular Cancer Therapeutics (2022) Vol. 21, Iss. 10, pp. 1608-1621
Open Access | Times Cited: 19
Bispecific CD33/CD123 targeted chimeric antigen receptor T cells for the treatment of acute myeloid leukemia
Justin C. Boucher, Bishwas Shrestha, Paresh Vishwasrao, et al.
Molecular Therapy — Oncolytics (2023) Vol. 31, pp. 100751-100751
Open Access | Times Cited: 11
CAR’TCR-T cells co-expressing CD33-CAR and dNPM1-TCR as superior dual-targeting approach for AML treatment
Karin Teppert, Isabella Ogusuku, Caroline Brandes, et al.
Deleted Journal (2024) Vol. 32, Iss. 2, pp. 200797-200797
Open Access | Times Cited: 4
CAR-T Therapy Beyond B-Cell Hematological Malignancies
Martina Canichella, Paolo de Fabritiis
Cells (2025) Vol. 14, Iss. 1, pp. 41-41
Open Access
New models for the development of and access to CAR T-cell therapies for children and adolescents with cancer: an ACCELERATE multistakeholder analysis
Andrew D.J. Pearson, Claudia Rössig, Crystal L. Mackall, et al.
The Lancet Oncology (2025) Vol. 26, Iss. 4, pp. e214-e224
Closed Access
Page 1 - Next Page

Scroll to top